If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Flavia Pagan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Thrombospondin 1 Medicine & Life Sciences
Anal Canal Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Interleukin-8 Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Vascular Endothelial Growth Factor A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 25 Citations
  • 2 h-Index
  • 5 Article
  • 1 Review article

Enteral versus intravenous approach for the sedation of critically ill patients: A randomized and controlled trial 11 Medical and Health Sciences 1103 Clinical Sciences

SedaEN investigators, Mistraletti, G., Umbrello, M., Salini, S., Cadringher, P., Formenti, P., Chiumello, D., Villa, C., Russo, R., Francesconi, S., Valdambrini, F., Bellani, G., Palo, A., Riccardi, F., Ferretti, E., Festa, M., Gado, A. M., Taverna, M., Pinna, C., Barbiero, A. & 2 others, Ferrari, P. A. & Iapichino, G., 2019, In : Critical Care. 23, 1, 3.

Research output: Contribution to journalArticle

1 Citation (Scopus)
Thrombospondin 1
Interleukin-8
Colorectal Neoplasms
Disease-Free Survival
Survival
4 Citations (Scopus)

Treatment of squamous cell carcinoma of the anal canal: A new strategies with anti-EGFR therapy and immunotherapy

Casadei Gardini, A., Passardi, A., Fornaro, L., Rosetti, P., Valgiusti, M., Ruscelli, S., Monti, M., Casadei, C., Pagan, F. & Frassineti, G. L., Mar 1 2018, In : Critical Reviews in Oncology/Hematology. 123, p. 52-56 5 p.

Research output: Contribution to journalReview article

Anal Canal
Epidermal Growth Factor Receptor
Immunotherapy
Squamous Cell Carcinoma
Therapeutics

Multicenter Prospective Study of Angiogenesis Polymorphism Validation in HCC Patients Treated with Sorafenib. An INNOVATE Study Protocol

Casadei Gardini, A., Faloppi, L., Aprile, G., Brunetti, O., Caparello, C., Corbelli, J., Chessa, L., Bruno, D., Ercolani, G., Leonetti, A., de Stefano, G., Farella, N., Foschi, F. G., Lanzi, A., Dadduzio, V., Marisi, G., Masi, G., Negri, F. V., Pagan, F., Santini, D. & 12 others, Scarpi, E., Silletta, M., Silvestris, N., Tamburini, E., Tassinari, D., Vivaldi, C., Gentilucci, U. V., Zagonel, V., Calvetti, L., Cascinu, S., Frassineti, G. L. & Scartozzi, M., Dec 1 2017, In : Tumori. p. tj5000704

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor A
Multicenter Studies
Hepatocellular Carcinoma
Disease-Free Survival
Prospective Studies